Company Number: 14328581

Analysis Date: 2025-07-20 12:42 UTC

Financial Health Assessment of GKB ESTATES LIMITED (As at 31 August 2023)

---

1. Financial Health Score: D

Explanation:
The company shows signs of financial distress, primarily due to negative net assets and net current liabilities. While it holds investment property as a significant fixed asset, current liabilities and long-term debt exceed available liquid assets, indicating potential liquidity challenges and a weak equity position. This grade reflects a company that is vulnerable and requires careful financial management to restore health.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Cash at bank	1,733	Very limited liquid cash; "low pulse" in cash flow
Current Liabilities	43,677	Immediate debts due within one year; high relative to cash
Net Current Assets (Working Capital)	-41,944	Negative working capital; "symptom of cash flow strain"
Fixed Assets (Investment Property)	132,740	Substantial long-term asset; "body mass" of the balance sheet
Total Assets Less Current Liabilities	90,796	Positive after offsetting current liabilities
Creditors Due After One Year (Bank Loans)	97,164	Long-term debt "chronic burden" affecting net worth
Net Assets / Shareholders’ Funds	-6,368	Negative equity; "financial health compromised"
Share Capital	2	Minimal capital invested by shareholders

---

3. Diagnosis

• Liquidity Distress: The company has a very low cash balance (£1,733) against current liabilities of £43,677, creating difficulties in meeting short-term obligations. Negative net current assets (-£41,944) are a clear "symptom of distress" indicating working capital insufficiency.

• Leverage Concerns: The company carries significant long-term debt (£97,164) relative to its net assets. This debt load creates a "chronic" financial strain, especially given the negative equity position (-£6,368). The equity is insufficient to buffer against liabilities.

• Asset Quality: The company's main asset is an investment property valued at £132,740. While this represents a strong tangible asset base ("healthy body mass"), the liquidity of such assets can be limited, and the market value can fluctuate, affecting solvency.

• Operating Results: The company reported a deficit of £6,370 in retained earnings, reflecting losses or expenses exceeding income during the period. This "weak heartbeat" suggests operational challenges or high financing costs.

• Company Stage: Incorporated recently in August 2022, still in early development, which often involves initial investment phases and financing arrangements that may not yet yield positive cash flows.

---

4. Recommendations

1. Improve Liquidity:

   • Seek to increase cash reserves through either operational income growth or additional equity injections.
   • Negotiate better payment terms with creditors or refinance short-term debts to reduce current liabilities pressure.
   • Monitor cash flow closely, aiming for a positive working capital position to ease immediate "breathlessness."

2. Debt Management:

   • Explore restructuring or refinancing options for the long-term bank loan to achieve more manageable repayment terms.
   • Consider capital injections from shareholders to reduce leverage and improve net asset position.

3. Asset Utilization:

   • Evaluate the investment property’s income-generating potential or consider partial sale or leasing to enhance cash inflows.
   • Conduct periodic revaluations to ensure asset values represent current market conditions.

4. Operational Efficiency:

   • Review operating expenses and revenue streams to identify opportunities to reduce losses.
   • Develop a strategic plan to move toward profitability and strengthen retained earnings.

5. Governance and Monitoring:

   • Directors should implement robust financial controls and regular financial health monitoring.
   • Engage with financial advisors or accountants for detailed cash flow forecasting and scenario planning.

---

Medical Analogy Summary

GKB ESTATES LIMITED exhibits "symptoms of financial distress," notably a "weak pulse" in liquidity and "negative equity" indicating the company’s "immune system" against financial shocks is compromised. The substantial investment property is a "vital organ" that provides value but lacks immediate liquidity. Without timely intervention—such as improving cash flow and managing debt—the company risks "financial illness" progressing further.

---